Avecho Biotechnology Limited Cash Flow-to-Debt Ratio
Avecho Biotechnology Limited cash flow-to-debt ratio. Avecho Biotechnology Limited (OEZ) has a Cash Flow-to-Debt Ratio of -0.88x as of December 2022, meaning its operating cash flow of €-808.80K could theoretically repay -1% of its total liabilities (€920.66K) in one year. Check Avecho Biotechnology Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Avecho Biotechnology Limited (2013–2022)
Cash flow-to-debt ratio of Avecho Biotechnology Limited from 2013 to 2022. Historical debt coverage capacity for Avecho Biotechnology Limited across 10 annual periods. Check OEZ cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Avecho Biotechnology Limited Cash Flow-to-Debt Ratio by Year (2013–2022)
Avecho Biotechnology Limited cash flow-to-debt ratio by year from 2013 to 2022. Year-by-year debt coverage analysis for Avecho Biotechnology Limited. For the full cash flow conversion analysis, see how efficiently does Avecho Biotechnology Limited generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -1.81x | €-1.67 Million | €920.66K | ▲ +58.6% |
| 2021 | -4.37x | €-3.10 Million | €709.36K | ▼ -114.8% |
| 2020 | -2.03x | €-1.42 Million | €700.17K | ▼ -196.0% |
| 2019 | 2.12x | €1.18 Million | €556.12K | ▲ +187.3% |
| 2018 | -2.43x | €-2.19 Million | €902.04K | ▲ +30.7% |
| 2017 | -3.50x | €-6.42 Million | €1.84 Million | ▲ +6.9% |
| 2016 | -3.76x | €-6.41 Million | €1.71 Million | ▲ +21.6% |
| 2015 | -4.79x | €-8.71 Million | €1.82 Million | ▼ -33.2% |
| 2014 | -3.60x | €-6.74 Million | €1.87 Million | ▲ +8.3% |
| 2013 | -3.92x | €-8.58 Million | €2.19 Million | — |